Literature DB >> 22915757

MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells.

Pinchas Tsukerman1, Noam Stern-Ginossar, Chamutal Gur, Ariella Glasner, Daphna Nachmani, Yoav Bauman, Rachel Yamin, Alon Vitenshtein, Noah Stanietsky, Tomer Bar-Mag, Dikla Lankry, Ofer Mandelboim.   

Abstract

Natural killer cells (NK) are a component of innate immunity well known for their potent ability to kill virus-infected or neoplastically transformed cells following stimulation of the NK cell receptor NKG2D. One of the various ligands of NKG2D is MICB, a stress-induced ligand that has been found to be upregulated on the surface of tumor cells. However, there is little knowledge about how this upregulation may occur or how it may be selected against in tumors as a mechanism of immune escape. Here, we report that the metastasis-associated microRNA (metastamir) miR-10b directly binds to the 3' untranslated region of MICB and downregulates its expression. Notably, antagonizing miR-10b action enhanced NKG2D-mediated killing of tumor cells in vitro and enhanced clearance of tumors in vivo. Conversely, overexpression of miR-10b downregulated MICB and impaired elimination of tumor cells. Together, our results define MICB as a novel immune target of miR-10b, implying a direct link between metastasis capability and immune escape from NK cells. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22915757     DOI: 10.1158/0008-5472.CAN-11-2671

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  60 in total

1.  The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression.

Authors:  Maxime Battistella; Martha Romero; Luis-Jaime Castro-Vega; Guillaume Gapihan; Fatiha Bouhidel; Martine Bagot; Jean-Paul Feugeas; Anne Janin
Journal:  J Invest Dermatol       Date:  2015-01-29       Impact factor: 8.551

Review 2.  The fundamental role of miR-10b in metastatic cancer.

Authors:  Patrick Sheedy; Zdravka Medarova
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

Review 3.  From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport.

Authors:  Alberto Dávalos; Carlos Fernández-Hernando
Journal:  Pharmacol Res       Date:  2013-02-19       Impact factor: 7.658

Review 4.  Molecular mechanisms of natural killer cell activation in response to cellular stress.

Authors:  C J Chan; M J Smyth; L Martinet
Journal:  Cell Death Differ       Date:  2013-04-12       Impact factor: 15.828

5.  Association between inflammation and cancer stem cell phenotype in breast cancer.

Authors:  Young Ju Jeong; Hoon Kyu Oh; Sung Hwan Park; Jin Gu Bong
Journal:  Oncol Lett       Date:  2017-12-13       Impact factor: 2.967

Review 6.  Exploiting microRNAs As Cancer Therapeutics.

Authors:  Tamsin Robb; Glen Reid; Cherie Blenkiron
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

Review 7.  The immune system and inflammation in breast cancer.

Authors:  Xinguo Jiang; David J Shapiro
Journal:  Mol Cell Endocrinol       Date:  2013-06-19       Impact factor: 4.102

8.  Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression.

Authors:  Jingyan Xie; Mengna Liu; Yujuan Li; Yunzhong Nie; Qiongyu Mi; Shuli Zhao
Journal:  Cell Mol Immunol       Date:  2014-05-12       Impact factor: 11.530

9.  Down-regulation of UL16-binding protein 3 mediated by interferon-gamma impairs immune killing in nasopharyngeal carcinoma.

Authors:  Lingling Guo; Yu Chen; Jing Wang; Chuanben Chen
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

10.  NKG2D-NKG2D Ligand Interaction Inhibits the Outgrowth of Naturally Arising Low-Grade B Cell Lymphoma In Vivo.

Authors:  Saravanan Raju; Lena Z Kretzmer; Olivia I Koues; Jacqueline E Payton; Eugene M Oltz; Amanda Cashen; Bojan Polic; Robert D Schreiber; Andrey S Shaw; Mary A Markiewicz
Journal:  J Immunol       Date:  2016-05-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.